Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the effects of high dose Estramustine phosphate and mitomycin C on the time to progression and length of survival of patients with progressive, advanced endocrine-independent prostatic cancer: an interim analysis of EORTC-GU Group study no. 30865.
Newling DW, Fossa S, Tunn U, Kurth KH, De Pauw M, Sylvester R. Newling DW, et al. Among authors: sylvester r. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):971-5. doi: 10.1016/0960-0760(90)90452-q. J Steroid Biochem Mol Biol. 1990. PMID: 2126739 Clinical Trial.
The chemotherapy of advanced bladder cancer.
Newling DW, Stoter G, Sylvester R, de Pauw M. Newling DW, et al. Among authors: sylvester r. Cancer Chemother Pharmacol. 1987;20 Suppl:S39-43. doi: 10.1007/BF00262483. Cancer Chemother Pharmacol. 1987. PMID: 3664943
Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study (30865).
Newling DW, Fossa SD, Tunn UW, Kurth KH, de Pauw M, Sylvester R. Newling DW, et al. Among authors: sylvester r. J Urol. 1993 Dec;150(6):1840-4. doi: 10.1016/s0022-5347(17)35911-6. J Urol. 1993. PMID: 8230517 Clinical Trial.
Orchidectomy versus Buserelin in combination with cyproterone acetate, for 2 weeks or continuously, in the treatment of metastatic prostatic cancer. Preliminary results of EORTC-trial 30843.
de Voogt HJ, Klijn JG, Studer U, Schröder F, Sylvester R, De Pauw M. de Voogt HJ, et al. Among authors: sylvester r. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):965-9. doi: 10.1016/0960-0760(90)90451-p. J Steroid Biochem Mol Biol. 1990. PMID: 2149509 Clinical Trial.
The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
Robinson MR, Smith PH, Richards B, Newling DW, de Pauw M, Sylvester R. Robinson MR, et al. Among authors: sylvester r. Eur Urol. 1995;28(4):273-83. Eur Urol. 1995. PMID: 8575493 Clinical Trial.
503 results